Protective effects of autophagy and NFE2L2 on reactive oxygen species-induced pyroptosis of human nucleus pulposus cells.
Autophagy
Female
Gene Expression Regulation
Humans
Inflammasomes
/ metabolism
Intervertebral Disc Degeneration
/ genetics
Male
Middle Aged
NF-E2-Related Factor 2
/ biosynthesis
Nucleus Pulposus
/ metabolism
Oxidative Stress
Pyroptosis
/ genetics
RNA
/ genetics
Reactive Oxygen Species
/ metabolism
Signal Transduction
autophagy
intervertebral disc degeneration
nucleus pulposus cells
pyroptosis
transcription factor
Journal
Aging
ISSN: 1945-4589
Titre abrégé: Aging (Albany NY)
Pays: United States
ID NLM: 101508617
Informations de publication
Date de publication:
22 04 2020
22 04 2020
Historique:
received:
14
01
2020
accepted:
04
03
2020
pubmed:
23
4
2020
medline:
24
2
2021
entrez:
23
4
2020
Statut:
ppublish
Résumé
Intervertebral disc degeneration (IDD) is characterized by the decrease of nucleus pulposus cells (NPCs). With the increase of the degree of degeneration, the reactive oxygen species (ROS) in nucleus pulposus tissue increases. Pyroptosis is a newly discovered form of cell death and its relationship with oxidative stress in NPCs remains unclear. This study was performed to investigate the mechanisms of pyroptosis of NPCs under oxidative stress. NPCs were isolated from IDD patients by surgical treatment. Pyroptosis related proteins like NLR family pyrin domain containing 3(NLRP3) and PYD and CARD domain containing (PYCARD) were detected by western blot, and membrane pore formation was observed by hochest33342/PI double staining or scanning electron microscope. The results showed that ROS induced the pyroptosis of NPCs and it depended on the expression of NLRP3 and PYCARD. The increased ROS level also increased transcription factor nuclear factor, erythroid 2 like 2 (NFE2L2, Nrf2) and the autophagy of NPCs, both of which attenuated the pyroptosis. In summary, ROS induces the pyroptosis of NPCs through the NLRP3/ PYCARD pathway, and establishes negative regulation by increasing autophagy and NFE2L2. These findings may provide a better understanding of the mechanism of IDD and potential therapeutic approaches for IDD treatment.
Identifiants
pubmed: 32320383
doi: 10.18632/aging.103109
pii: 103109
pmc: PMC7202523
doi:
Substances chimiques
Inflammasomes
0
NF-E2-Related Factor 2
0
NFE2L2 protein, human
0
Reactive Oxygen Species
0
RNA
63231-63-0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
7534-7548Références
Blood. 2010 Jul 1;115(26):5398-400
pubmed: 20407038
Lancet. 2016 Oct 8;388(10053):1603-1658
pubmed: 27733283
J Immunol. 2008 Jun 15;180(12):8410-20
pubmed: 18523309
Eur J Immunol. 2017 May;47(5):806-817
pubmed: 28247911
Nat Immunol. 2008 Aug;9(8):866-72
pubmed: 18604212
Blood. 2010 Sep 2;116(9):1570-3
pubmed: 20495074
J Agric Food Chem. 2017 May 17;65(19):3811-3818
pubmed: 28459555
Inflammation. 2016 Dec;39(6):1853-1861
pubmed: 27605220
Osteoarthritis Cartilage. 2019 Jan;27(1):41-48
pubmed: 30243946
Evid Based Complement Alternat Med. 2015;2015:386012
pubmed: 25763091
Cell Mol Immunol. 2015 Jul;12(4):424-34
pubmed: 25109682
Science. 2008 May 2;320(5876):674-7
pubmed: 18403674
Arthritis Res Ther. 2017 Sep 18;19(1):209
pubmed: 28923094
J Orthop Res. 2013 Jul;31(7):1150-7
pubmed: 23389888
Eur J Pharmacol. 2016 Jun 5;780:8-15
pubmed: 26921756
Med Oncol. 2016 Jan;33(1):10
pubmed: 26715036
Nat Immunol. 2010 Dec;11(12):1136-42
pubmed: 21057511
Joint Bone Spine. 2014 Mar;81(2):125-9
pubmed: 23932724
J Med Food. 2018 Jan;21(1):13-20
pubmed: 28976796
Cell Death Dis. 2018 Feb 7;9(2):171
pubmed: 29416034
J Biol Chem. 2014 Jun 13;289(24):17020-9
pubmed: 24798340
Eur J Immunol. 2011 Jul;41(7):2040-51
pubmed: 21484785
Life Sci. 2016 Jul 15;157:45-51
pubmed: 27153777
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3030-3
pubmed: 20133696
Autophagy. 2016 Sep;12(9):1631-46
pubmed: 27314664
Indian J Orthop. 2010 Apr;44(2):184-90
pubmed: 20419006
Spine J. 2009 Aug;9(8):658-66
pubmed: 19540815
J Biol Chem. 2007 Feb 2;282(5):2871-9
pubmed: 17132626
Arch Gerontol Geriatr. 2014 Nov-Dec;59(3):665-9
pubmed: 25081833
Biochem Biophys Res Commun. 2018 Oct 2;504(2):406-414
pubmed: 29890141
Biochem Biophys Res Commun. 2012 Aug 24;425(2):384-9
pubmed: 22842458
Eur J Pharmacol. 2016 Jan 5;770:85-91
pubmed: 26668000
Sci Rep. 2017 Jan 25;7:41067
pubmed: 28120948
Biomed Pharmacother. 2018 Mar;99:725-734
pubmed: 29710470
Sci Rep. 2014 Dec 12;4:7456
pubmed: 25503852